Upload
job-potter
View
215
Download
0
Tags:
Embed Size (px)
Citation preview
LADUCA Group CPD
•Michael Miliken (junk bond wizard)•Arnold Palmer (golf master)•Francois Mitterand (French president)•Charles de Gaulle (vive le Quebec libre)•Ayatollah Komeini (Ayatollah)•Robert Dole (senior politician)•Rudolph Giuliani (mayor NYC)•Rupert Murdoch (media mogul)•Sir Alec Guinness (Obi-Wan Kenobi)•Sidney Poitier (actor)•Sean Connery (007)•Roger Moore (007)•Pierre Elliott Trudeau (Prime Minister)•Andy Grove (Intel corp)•Marv Levy (Buffalo Bills Head Coach)•Preston Manning (politician)•Linus Pauling (Nobel x 2)•Eddie Shack (‘clear the track’)•Charleton Heston (Moses)•Frank Zappa (musician)
Who Develops Prostate Cancer?
0
500
1000
1500
2000
2500
3000
3500
1990 1993 1996 1999 2002 2005
Ca. Prostate: No.
Ca. Prostate : Deaths
Prostate Cancer: Not The Only Cause Of Death In Men
What/where is the prostate? Who is at risk? Diagnosis How aggressive is the cancer (grading) How advanced is the cancer (staging) What are the treatment options for
localised and advanced prostate cancer What is the outlook after treatment
Majority of seminal fluid is prostatic in origin: average ejaculate volume= 2-5 mls; only 0.1-0.2 mls = sperm
“Nourishment and support” of sperm in the ejaculate
Provision of income for Urologists!
»Beyond Your control:»Age»Testosterone»Race »Family history
»Lifestyle»Geography»Diet
Prostate Cancer Risk Factors
Race and Nationality Mortality Rates
Per 100,000
Low-fat diet Soy products tomatoes Nutritional
supplements Selenium, vitamin E
Lifestyle - exercise, BMI
Herbal preparations
Holistic Approaches to Prevention
•symptoms not helpful
Digital Rectal Examination (DRE)
Prostate SpecificAntigen (PSA)
TransrectalUltrasound
(TRUS)
DiagnosticTriad
Early Diagnosis of Prostate Cancer
Majority diagnosed on PSA (Prostate Specific Antigen) testing with nil symptoms and normal rectal examination
Presentation with urinary symptoms Abnormal findings on rectal examination Presentation with symptoms of advanced
disease eg bone pain or fracture due to cancer spread to bone
Incidental diagnosis following prostate surgery
“Blockage of the bladder”- poor flow, hesitancy, intermittency of flow, urgency retention of urine
“Irritation” of the bladder- frequency day/night, urgency, urge leakage
Kidney obstruction and kidney failure
Produced by both benign and malignant prostate disease – benign enlargement, prostate infection and prostate cancer
Not elevated by other cancers ↑ levels with ↑ age: -age scale
40-50 2-2.550-60 2.5-3.560-70 3.5-5.070-80 5.0-7.0
The case for screening The lengthy preclinical detectable
phase of prostate cancer allows for early detection
Devastating effects of metastatic prostate cancer
Availability of convenient and inexpensive screening tests (DRE and PSA)
Treatments for early disease
The case against screening Inconsistency in disease progression High prevalence of asymptomatic
disease Does screening do more harm than
good? No evidence on benefits available from
randomized clinical trials Excess cost, morbidity and mortality from
treatments
American, Canadian Cancer Society - annual PSA&DRE men >50 (discuss)
AUA, CUA- annual PSA&DRE men >50 (discuss)
CTFPH (GPs), USPSTF- recommend against screening (grade
D evidence)
This will not be resolved until results of PLCO and ER-SPC studies (?2009-10)
Does PSA screening predict risk of Prostate Cancer? Yes
Does PSA screening predict clinically significant prostate cancer? Probably
Does PSA screening improve survival? Only future studies can prove
Sample of prostate must be taken to confirm diagnosis: prostate biopsy
Day stay local anaesthetic/sedation procedure
Generally 12 cores taken from throughout the prostate
Risksbleedinginfectionpain retention
Diagnosed on prostate biopsy
Factors determining treatment:
Cancer Grade- how aggressive is it?Cancer Stage- has it spread beyond the
prostatePSA levelGeneral health issuesPatient views
Gleason Score: Pathologist determines from recognised patterns the aggressiveness of the disease
Gleason score: 6-10 Gleason 6: favourable Gleason 10: highly aggresive
Has the cancer extended outside of the prostate?
Rectal examination findings
X raysMRI pelvisbone scanchest xray
Localised prostate cancerProstate removal (radical prostatectomy)Radiation Treatment-external beam radiation-brachytherapy (radioactive seed implantation)
Advanced prostate cancerAndrogen deprivation treatmentChemotherapyRadiation/palliative measures
Open surgery, Laparoscopic surgery, Robotic surgery
Works well if cancer confined within the prostate
Long term adverse effectsincontinenceimpotence
Long duration of treatment: 6-8 weeks after planning
Limited resource available Long term adverse effectsoveractive bladder/bowel symptoms
Minimally invasive treatment Suitable for early and low grade prostate
cancer Not satisfactory for large prostates Overnight stay/return to full function quickly Long term data: ? Better outcome than
surgery Long term adverse effectsbladder obstruction/overactive bladder
symptoms
>75% long term disease free survival with treatment.
Probably similar outcomes for surgery and radiation treatment
Huggins C, Hodges CV: The effect of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941;1:293–297.
Charles Huggins (Nobel 1966)“Discovery is our business”
Hormone deprivation (androgen deprivation) treatment
Can be facilitated by drugs or removal of both testis- adverse effects of hormone loss
Eventual “escape” of disease in most patients
Not curative Taxol based chemotherapy offers some
hope Palliative measures available eg radiation
NZ: 3000 new cases diagnosed a year: 600 deaths/year
Dramatic rise in incidence since use of PSA testing
The use of PSA as a screening test remains controversial
Effective treatment for early prostate cancer is available
Advanced prostate cancer is not curable